Swine Vaccines Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Swine Vaccines market size was valued at USD 1419.1 million in 2022 and is forecast to a readjusted size of USD 1846 million by 2029 with a CAGR of 3.8% during review period.

The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialized body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.

Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.

Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.

China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.

This report is a detailed and comprehensive analysis for global Swine Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Swine Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2018-2029
Global Swine Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2018-2029
Global Swine Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/K Doses), 2018-2029
Global Swine Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (USD/K Doses), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Swine Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Swine Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   Merck
   Boehringer Ingelheim
   Jinyu Bio-Technology
   CAHIC
   Tecon
   Zoetis
   Ceva
   Hile Bio
   Chopper Biology
   WINSUN
   Hipra
   Ringpu Biology
   ChengDu Tecbond
   DHN
   CAVAC
   Virbac
   HVRI
   Bioveta

   CSF Vaccines
   FMD Vaccines
   Porcine Circovirus Vaccines
   PRRS Vaccines
   Others
 

   Government Tender
   Market Sales

   North America (United States, Canada and Mexico)
   Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
   South America (Brazil, Argentina, Colombia, and Rest of South America)
   Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

What are the strengths of the swine vaccines market in 2025?

The swine vaccines market benefits from increasing demand for disease prevention in livestock, ensuring better productivity and minimizing economic losses. The development of advanced vaccines that offer broader protection and longer-lasting effects strengthens the market. Additionally, rising awareness about animal health among farmers and government support for disease control contribute to market growth.

What weaknesses might the swine vaccines market face in 2025?

High production costs and limited accessibility of vaccines in developing regions could hinder market expansion. Moreover, concerns about vaccine safety and the potential for resistance to vaccines may pose challenges to growth. The complexity of the regulatory environment also slows down the approval of new vaccine formulations.

What opportunities exist for the swine vaccines market in 2025?

The growing global demand for pork and the push for sustainable farming practices provide significant opportunities. Innovations in vaccine technology, such as mRNA vaccines, could lead to more effective and affordable options. Additionally, increasing investment in veterinary healthcare and expanding markets in emerging economies present new avenues for growth.

What threats could impact the swine vaccines market in 2025?

The threat of emerging infectious diseases and the potential for zoonotic diseases to spread may disrupt the market. Additionally, economic instability or trade restrictions could negatively affect vaccine distribution and livestock farming. Lastly, competition from alternative disease control methods, such as genetic engineering, might challenge the dominance of vaccines in the swine health sector.

What political factors could impact the swine vaccines market in 2025?

Government policies on livestock health and disease control significantly affect the market. Supportive regulations and subsidies for animal health initiatives can foster growth. However, political instability or shifting regulations in key markets may disrupt vaccine supply chains or delay product approvals.

How might economic conditions influence the swine vaccines market in 2025?

Economic growth in emerging markets could drive increased demand for swine vaccines as farmers invest more in livestock health. Conversely, economic downturns may lead to reduced spending on non-essential products, including vaccines. Price sensitivity in low-income regions could also limit market access to vaccines.

What social factors could shape the swine vaccines market in 2025?

Rising consumer awareness about food safety and the health of livestock can lead to greater demand for effective vaccines. Additionally, changing dietary habits, particularly the increase in pork consumption in developing countries, could drive the need for better disease prevention methods. Public concern over the welfare of farm animals also pushes for better vaccine options.

What technological factors may influence the swine vaccines market in 2025?

Advancements in vaccine development, such as the use of mRNA technology or more targeted vaccines, could revolutionize the market. Increased automation in production processes can lower costs and increase efficiency. However, the need for ongoing research and development to stay ahead of emerging diseases remains a key technological challenge.

What environmental factors are relevant to the swine vaccines market in 2025?

Sustainability concerns, including the environmental impact of livestock farming, may influence vaccine use as part of broader efforts to reduce agricultural pollution. Climate change could also introduce new diseases, creating the need for new vaccines. Furthermore, environmental regulations around animal farming could encourage or require better disease prevention practices.

What legal factors could affect the swine vaccines market in 2025?

Stringent regulations on vaccine approval, safety standards, and intellectual property rights can significantly affect market dynamics. Legal challenges related to vaccine patents or disputes over the effectiveness and safety of certain vaccine types may also impact market growth. Additionally, animal welfare laws could push for more ethical vaccine production practices.

Who are the suppliers in the swine vaccines market in 2025?

The suppliers include pharmaceutical companies, biotechnology firms, and research institutions that produce and develop swine vaccines. They provide the raw materials, research, and technology necessary for vaccine production.

What inputs are essential for the swine vaccines market in 2025?

Inputs include advanced research and development (R&D), raw materials for vaccine formulation, manufacturing technology, regulatory approval processes, and distribution networks. These elements are crucial for ensuring the vaccines are effective, safe, and accessible.

What processes are involved in the swine vaccines market in 2025?

The key processes include vaccine research and development, clinical trials, regulatory approval, production, packaging, and distribution. These processes ensure that vaccines meet safety standards, are manufactured efficiently, and reach the market for use by farmers and livestock operators.

Who are the customers in the swine vaccines market in 2025?

The primary customers are livestock farmers, veterinary clinics, agribusinesses, and governmental bodies involved in animal health. Additionally, distributors and retail pharmacies play a role in reaching end users in various regions.

What outputs are delivered by the swine vaccines market in 2025?

The outputs are the vaccines themselves, which are delivered to farms and veterinary clinics for administration to pigs. These vaccines help prevent diseases, improve livestock health, and enhance overall productivity in the swine industry.

How strong is the threat of new entrants in the swine vaccines market in 2025?

The threat of new entrants is moderate. While the market holds growth potential, the high barriers to entry such as regulatory hurdles, substantial R&D costs, and the need for established distribution networks make it difficult for new companies to enter and compete with established players.

How intense is the bargaining power of suppliers in the swine vaccines market in 2025?

The bargaining power of suppliers is moderate to high. Suppliers of raw materials, specialized equipment, and cutting-edge technologies have significant influence, particularly because vaccine production requires high-quality inputs and adherence to strict regulatory standards.

How strong is the bargaining power of buyers in the swine vaccines market in 2025?

The bargaining power of buyers is moderate. While large-scale farms or governments have some leverage due to volume purchases, the overall demand for disease prevention in livestock gives manufacturers some power, especially when vaccines are crucial for preventing economic losses due to disease outbreaks.

How intense is the threat of substitute products in the swine vaccines market in 2025?

The threat of substitutes is low to moderate. Alternatives such as genetic engineering, improved farming practices, or other forms of disease management exist, but vaccines remain one of the most effective and reliable methods for large-scale disease prevention in swine farming.

How competitive is the rivalry among existing firms in the swine vaccines market in 2025?

The competition is moderate to high. While a few large players dominate the market, there are opportunities for innovation and differentiation, particularly in terms of vaccine effectiveness, delivery methods, and cost. However, the large initial investments required for R&D and regulatory approval limit the number of competitors.

What are the key raw materials required in the swine vaccines market in 2025?

The key raw materials include antigens, adjuvants, stabilizers, preservatives, and excipients. These ingredients are essential for the formulation of vaccines that are both effective and safe for swine.

What role do research and development (R&D) play in the swine vaccines market in 2025?

R&D is critical in the development of new vaccines, including those targeting emerging diseases or offering broader protection. Investment in R&D leads to the creation of more effective, efficient, and long-lasting vaccines, thus enhancing the competitiveness of manufacturers.

How important are regulatory bodies in the upstream process of the swine vaccines market in 2025?

Regulatory bodies are crucial in ensuring that vaccines meet safety, efficacy, and quality standards. They play a central role in approving new vaccine formulations and ensuring compliance with local and international standards, which can significantly impact production timelines and market access.

How does the availability of manufacturing technology impact the swine vaccines market in 2025?

Advanced manufacturing technology directly influences the cost, efficiency, and scalability of vaccine production. New technologies, such as automated production lines or improvements in vaccine delivery systems, can streamline manufacturing, reduce costs, and ensure consistent product quality.

What is the role of suppliers in the upstream supply chain of the swine vaccines market in 2025?

Suppliers provide the essential components needed for vaccine production, including raw materials, laboratory equipment, and specialized technologies. Their reliability and ability to innovate directly affect the speed and cost of vaccine development and production.

What are the key manufacturing processes involved in the swine vaccines market in 2025?

Key manufacturing processes include antigen production, vaccine formulation, quality control, and packaging. Advanced techniques such as cell culture or recombinant DNA technology are often used to produce the active ingredients, ensuring the vaccine's efficacy and safety.

How does quality control impact the swine vaccines market in 2025?

Quality control is essential to ensure the safety, potency, and consistency of each vaccine batch. Stringent testing for sterility, stability, and efficacy ensures that vaccines meet regulatory standards and are safe for widespread use in livestock.

What role does logistics play in the midstream process of the swine vaccines market in 2025?

Logistics are crucial for ensuring the timely and safe delivery of vaccines to farms, veterinary clinics, and distributors. This includes managing temperature-sensitive shipments, maintaining the cold chain, and coordinating distribution networks to ensure vaccines reach their destination without degradation.

How significant are partnerships and collaborations in the swine vaccines market in 2025?

Partnerships between vaccine manufacturers, research institutions, and government agencies are increasingly important for accelerating vaccine development and distribution. Collaborations can help with resource sharing, market access, and addressing emerging diseases, ultimately enhancing the efficiency of the midstream supply chain.

How does regulatory compliance influence the midstream processes in the swine vaccines market in 2025?

Regulatory compliance plays a central role in the midstream process. Vaccines must meet strict regulatory standards for manufacturing, packaging, and distribution. Compliance with local and international regulations ensures that vaccines are safe and effective for use in different regions, influencing manufacturing strategies and market access.

What are the key distribution channels in the swine vaccines market in 2025?

Key distribution channels include direct sales to large farms, veterinary clinics, and government programs. Distributors and wholesalers also play a significant role in reaching smaller farms and rural areas. Online platforms for ordering and veterinary pharmacies are becoming increasingly important as well.

How does pricing impact the downstream aspects of the swine vaccines market in 2025?

Pricing is a crucial factor, as it affects the affordability and accessibility of vaccines, especially in price-sensitive regions. Competitive pricing strategies are essential for market penetration, particularly in emerging markets. High vaccine prices may limit adoption, while cost-effective solutions could lead to broader usage.

How important is customer education in the downstream process of the swine vaccines market in 2025?

Customer education is vital for ensuring that farmers and veterinarians understand the benefits and proper usage of vaccines. Effective communication about disease prevention and the long-term financial benefits of vaccination can drive demand and improve adoption rates in the market.

What role does post-sale support play in the swine vaccines market in 2025?

Post-sale support, including follow-up services, troubleshooting, and customer service, is important for maintaining customer satisfaction and ensuring the vaccines are used properly. Support services can also provide additional opportunities for manufacturers to offer training or maintenance services, strengthening customer relationships.

How do regulatory requirements affect the downstream processes in the swine vaccines market in 2025?

Regulatory requirements influence the packaging, labeling, and sale of vaccines. Compliance with local regulations ensures that vaccines can be legally marketed and used in specific regions. Non-compliance can result in delays or bans on vaccine sales, impacting the overall distribution strategy.

Chapter 1, to describe Swine Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Swine Vaccines, with price, sales, revenue and global market share of Swine Vaccines from 2018 to 2023.
Chapter 3, the Swine Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Swine Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Swine Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Swine Vaccines.
Chapter 14 and 15, to describe Swine Vaccines sales channel, distributors, customers, research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Swine Vaccines
   1.2 Market Estimation Caveats and Base Year
   1.3 Market Analysis by Type
       1.3.1 Overview: Global Swine Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
       1.3.2 CSF Vaccines
       1.3.3 FMD Vaccines
       1.3.4 Porcine Circovirus Vaccines
       1.3.5 PRRS Vaccines
       1.3.6 Others
   1.4 Market Analysis by Application
       1.4.1 Overview: Global Swine Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Government Tender
       1.4.3 Market Sales
   1.5 Global Swine Vaccines Market Size & Forecast
       1.5.1 Global Swine Vaccines Consumption Value (2018 & 2022 & 2029)
       1.5.2 Global Swine Vaccines Sales Quantity (2018-2029)
       1.5.3 Global Swine Vaccines Average Price (2018-2029)

2 Manufacturers Profiles

   2.1 Merck
       2.1.1 Merck Details
       2.1.2 Merck Major Business
       2.1.3 Merck Swine Vaccines Product and Services
       2.1.4 Merck Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Merck Recent Developments/Updates
   2.2 Boehringer Ingelheim
       2.2.1 Boehringer Ingelheim Details
       2.2.2 Boehringer Ingelheim Major Business
       2.2.3 Boehringer Ingelheim Swine Vaccines Product and Services
       2.2.4 Boehringer Ingelheim Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Boehringer Ingelheim Recent Developments/Updates
   2.3 Jinyu Bio-Technology
       2.3.1 Jinyu Bio-Technology Details
       2.3.2 Jinyu Bio-Technology Major Business
       2.3.3 Jinyu Bio-Technology Swine Vaccines Product and Services
       2.3.4 Jinyu Bio-Technology Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Jinyu Bio-Technology Recent Developments/Updates
   2.4 CAHIC
       2.4.1 CAHIC Details
       2.4.2 CAHIC Major Business
       2.4.3 CAHIC Swine Vaccines Product and Services
       2.4.4 CAHIC Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 CAHIC Recent Developments/Updates
   2.5 Tecon
       2.5.1 Tecon Details
       2.5.2 Tecon Major Business
       2.5.3 Tecon Swine Vaccines Product and Services
       2.5.4 Tecon Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Tecon Recent Developments/Updates
   2.6 Zoetis
       2.6.1 Zoetis Details
       2.6.2 Zoetis Major Business
       2.6.3 Zoetis Swine Vaccines Product and Services
       2.6.4 Zoetis Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Zoetis Recent Developments/Updates
   2.7 Ceva
       2.7.1 Ceva Details
       2.7.2 Ceva Major Business
       2.7.3 Ceva Swine Vaccines Product and Services
       2.7.4 Ceva Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 Ceva Recent Developments/Updates
   2.8 Hile Bio
       2.8.1 Hile Bio Details
       2.8.2 Hile Bio Major Business
       2.8.3 Hile Bio Swine Vaccines Product and Services
       2.8.4 Hile Bio Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Hile Bio Recent Developments/Updates
   2.9 Chopper Biology
       2.9.1 Chopper Biology Details
       2.9.2 Chopper Biology Major Business
       2.9.3 Chopper Biology Swine Vaccines Product and Services
       2.9.4 Chopper Biology Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 Chopper Biology Recent Developments/Updates
   2.10 WINSUN
       2.10.1 WINSUN Details
       2.10.2 WINSUN Major Business
       2.10.3 WINSUN Swine Vaccines Product and Services
       2.10.4 WINSUN Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.10.5 WINSUN Recent Developments/Updates
   2.11 Hipra
       2.11.1 Hipra Details
       2.11.2 Hipra Major Business
       2.11.3 Hipra Swine Vaccines Product and Services
       2.11.4 Hipra Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.11.5 Hipra Recent Developments/Updates
   2.12 Ringpu Biology
       2.12.1 Ringpu Biology Details
       2.12.2 Ringpu Biology Major Business
       2.12.3 Ringpu Biology Swine Vaccines Product and Services
       2.12.4 Ringpu Biology Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.12.5 Ringpu Biology Recent Developments/Updates
   2.13 ChengDu Tecbond
       2.13.1 ChengDu Tecbond Details
       2.13.2 ChengDu Tecbond Major Business
       2.13.3 ChengDu Tecbond Swine Vaccines Product and Services
       2.13.4 ChengDu Tecbond Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.13.5 ChengDu Tecbond Recent Developments/Updates
   2.14 DHN
       2.14.1 DHN Details
       2.14.2 DHN Major Business
       2.14.3 DHN Swine Vaccines Product and Services
       2.14.4 DHN Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.14.5 DHN Recent Developments/Updates
   2.15 CAVAC
       2.15.1 CAVAC Details
       2.15.2 CAVAC Major Business
       2.15.3 CAVAC Swine Vaccines Product and Services
       2.15.4 CAVAC Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.15.5 CAVAC Recent Developments/Updates
   2.16 Virbac
       2.16.1 Virbac Details
       2.16.2 Virbac Major Business
       2.16.3 Virbac Swine Vaccines Product and Services
       2.16.4 Virbac Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.16.5 Virbac Recent Developments/Updates
   2.17 HVRI
       2.17.1 HVRI Details
       2.17.2 HVRI Major Business
       2.17.3 HVRI Swine Vaccines Product and Services
       2.17.4 HVRI Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.17.5 HVRI Recent Developments/Updates
   2.18 Bioveta
       2.18.1 Bioveta Details
       2.18.2 Bioveta Major Business
       2.18.3 Bioveta Swine Vaccines Product and Services
       2.18.4 Bioveta Swine Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.18.5 Bioveta Recent Developments/Updates

3 Competitive Environment: Swine Vaccines by Manufacturer

   3.1 Global Swine Vaccines Sales Quantity by Manufacturer (2018-2023)
   3.2 Global Swine Vaccines Revenue by Manufacturer (2018-2023)
   3.3 Global Swine Vaccines Average Price by Manufacturer (2018-2023)
   3.4 Market Share Analysis (2022)
       3.4.1 Producer Shipments of Swine Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
       3.4.2 Top 3 Swine Vaccines Manufacturer Market Share in 2022
       3.4.2 Top 6 Swine Vaccines Manufacturer Market Share in 2022
   3.5 Swine Vaccines Market: Overall Company Footprint Analysis
       3.5.1 Swine Vaccines Market: Region Footprint
       3.5.2 Swine Vaccines Market: Company Product Type Footprint
       3.5.3 Swine Vaccines Market: Company Product Application Footprint
   3.6 New Market Entrants and Barriers to Market Entry
   3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

   4.1 Global Swine Vaccines Market Size by Region
       4.1.1 Global Swine Vaccines Sales Quantity by Region (2018-2029)
       4.1.2 Global Swine Vaccines Consumption Value by Region (2018-2029)
       4.1.3 Global Swine Vaccines Average Price by Region (2018-2029)
   4.2 North America Swine Vaccines Consumption Value (2018-2029)
   4.3 Europe Swine Vaccines Consumption Value (2018-2029)
   4.4 Asia-Pacific Swine Vaccines Consumption Value (2018-2029)
   4.5 South America Swine Vaccines Consumption Value (2018-2029)
   4.6 Middle East and Africa Swine Vaccines Consumption Value (2018-2029)

5 Market Segment by Type

   5.1 Global Swine Vaccines Sales Quantity by Type (2018-2029)
   5.2 Global Swine Vaccines Consumption Value by Type (2018-2029)
   5.3 Global Swine Vaccines Average Price by Type (2018-2029)

6 Market Segment by Application

   6.1 Global Swine Vaccines Sales Quantity by Application (2018-2029)
   6.2 Global Swine Vaccines Consumption Value by Application (2018-2029)
   6.3 Global Swine Vaccines Average Price by Application (2018-2029)

7 North America

   7.1 North America Swine Vaccines Sales Quantity by Type (2018-2029)
   7.2 North America Swine Vaccines Sales Quantity by Application (2018-2029)
   7.3 North America Swine Vaccines Market Size by Country
       7.3.1 North America Swine Vaccines Sales Quantity by Country (2018-2029)
       7.3.2 North America Swine Vaccines Consumption Value by Country (2018-2029)
       7.3.3 United States Market Size and Forecast (2018-2029)
       7.3.4 Canada Market Size and Forecast (2018-2029)
       7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

   8.1 Europe Swine Vaccines Sales Quantity by Type (2018-2029)
   8.2 Europe Swine Vaccines Sales Quantity by Application (2018-2029)
   8.3 Europe Swine Vaccines Market Size by Country
       8.3.1 Europe Swine Vaccines Sales Quantity by Country (2018-2029)
       8.3.2 Europe Swine Vaccines Consumption Value by Country (2018-2029)
       8.3.3 Germany Market Size and Forecast (2018-2029)
       8.3.4 France Market Size and Forecast (2018-2029)
       8.3.5 United Kingdom Market Size and Forecast (2018-2029)
       8.3.6 Russia Market Size and Forecast (2018-2029)
       8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

   9.1 Asia-Pacific Swine Vaccines Sales Quantity by Type (2018-2029)
   9.2 Asia-Pacific Swine Vaccines Sales Quantity by Application (2018-2029)
   9.3 Asia-Pacific Swine Vaccines Market Size by Region
       9.3.1 Asia-Pacific Swine Vaccines Sales Quantity by Region (2018-2029)
       9.3.2 Asia-Pacific Swine Vaccines Consumption Value by Region (2018-2029)
       9.3.3 China Market Size and Forecast (2018-2029)
       9.3.4 Japan Market Size and Forecast (2018-2029)
       9.3.5 Korea Market Size and Forecast (2018-2029)
       9.3.6 India Market Size and Forecast (2018-2029)
       9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
       9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

   10.1 South America Swine Vaccines Sales Quantity by Type (2018-2029)
   10.2 South America Swine Vaccines Sales Quantity by Application (2018-2029)
   10.3 South America Swine Vaccines Market Size by Country
       10.3.1 South America Swine Vaccines Sales Quantity by Country (2018-2029)
       10.3.2 South America Swine Vaccines Consumption Value by Country (2018-2029)
       10.3.3 Brazil Market Size and Forecast (2018-2029)
       10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

   11.1 Middle East & Africa Swine Vaccines Sales Quantity by Type (2018-2029)
   11.2 Middle East & Africa Swine Vaccines Sales Quantity by Application (2018-2029)
   11.3 Middle East & Africa Swine Vaccines Market Size by Country
       11.3.1 Middle East & Africa Swine Vaccines Sales Quantity by Country (2018-2029)
       11.3.2 Middle East & Africa Swine Vaccines Consumption Value by Country (2018-2029)
       11.3.3 Turkey Market Size and Forecast (2018-2029)
       11.3.4 Egypt Market Size and Forecast (2018-2029)
       11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
       11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

   12.1 Swine Vaccines Market Drivers
   12.2 Swine Vaccines Market Restraints
   12.3 Swine Vaccines Trends Analysis
   12.4 Porters Five Forces Analysis
       12.4.1 Threat of New Entrants
       12.4.2 Bargaining Power of Suppliers
       12.4.3 Bargaining Power of Buyers
       12.4.4 Threat of Substitutes
       12.4.5 Competitive Rivalry
   12.5 Influence of COVID-19 and Russia-Ukraine War
       12.5.1 Influence of COVID-19
       12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

   13.1 Raw Material of Swine Vaccines and Key Manufacturers
   13.2 Manufacturing Costs Percentage of Swine Vaccines
   13.3 Swine Vaccines Production Process
   13.4 Swine Vaccines Industrial Chain

14 Shipments by Distribution Channel

   14.1 Sales Channel
       14.1.1 Direct to End-User
       14.1.2 Distributors
   14.2 Swine Vaccines Typical Distributors
   14.3 Swine Vaccines Typical Customers

15 Research Findings and Conclusion

16 Appendix

   16.1 Methodology
   16.2 Research Process and Data Source
   16.3 Disclaimer

List of Tables

   Table 1. Global Swine Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Swine Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Merck Basic Information, Manufacturing Base and Competitors
   Table 4. Merck Major Business
   Table 5. Merck Swine Vaccines Product and Services
   Table 6. Merck Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 7. Merck Recent Developments/Updates
   Table 8. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
   Table 9. Boehringer Ingelheim Major Business
   Table 10. Boehringer Ingelheim Swine Vaccines Product and Services
   Table 11. Boehringer Ingelheim Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 12. Boehringer Ingelheim Recent Developments/Updates
   Table 13. Jinyu Bio-Technology Basic Information, Manufacturing Base and Competitors
   Table 14. Jinyu Bio-Technology Major Business
   Table 15. Jinyu Bio-Technology Swine Vaccines Product and Services
   Table 16. Jinyu Bio-Technology Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 17. Jinyu Bio-Technology Recent Developments/Updates
   Table 18. CAHIC Basic Information, Manufacturing Base and Competitors
   Table 19. CAHIC Major Business
   Table 20. CAHIC Swine Vaccines Product and Services
   Table 21. CAHIC Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 22. CAHIC Recent Developments/Updates
   Table 23. Tecon Basic Information, Manufacturing Base and Competitors
   Table 24. Tecon Major Business
   Table 25. Tecon Swine Vaccines Product and Services
   Table 26. Tecon Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 27. Tecon Recent Developments/Updates
   Table 28. Zoetis Basic Information, Manufacturing Base and Competitors
   Table 29. Zoetis Major Business
   Table 30. Zoetis Swine Vaccines Product and Services
   Table 31. Zoetis Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 32. Zoetis Recent Developments/Updates
   Table 33. Ceva Basic Information, Manufacturing Base and Competitors
   Table 34. Ceva Major Business
   Table 35. Ceva Swine Vaccines Product and Services
   Table 36. Ceva Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 37. Ceva Recent Developments/Updates
   Table 38. Hile Bio Basic Information, Manufacturing Base and Competitors
   Table 39. Hile Bio Major Business
   Table 40. Hile Bio Swine Vaccines Product and Services
   Table 41. Hile Bio Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 42. Hile Bio Recent Developments/Updates
   Table 43. Chopper Biology Basic Information, Manufacturing Base and Competitors
   Table 44. Chopper Biology Major Business
   Table 45. Chopper Biology Swine Vaccines Product and Services
   Table 46. Chopper Biology Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 47. Chopper Biology Recent Developments/Updates
   Table 48. WINSUN Basic Information, Manufacturing Base and Competitors
   Table 49. WINSUN Major Business
   Table 50. WINSUN Swine Vaccines Product and Services
   Table 51. WINSUN Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 52. WINSUN Recent Developments/Updates
   Table 53. Hipra Basic Information, Manufacturing Base and Competitors
   Table 54. Hipra Major Business
   Table 55. Hipra Swine Vaccines Product and Services
   Table 56. Hipra Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 57. Hipra Recent Developments/Updates
   Table 58. Ringpu Biology Basic Information, Manufacturing Base and Competitors
   Table 59. Ringpu Biology Major Business
   Table 60. Ringpu Biology Swine Vaccines Product and Services
   Table 61. Ringpu Biology Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 62. Ringpu Biology Recent Developments/Updates
   Table 63. ChengDu Tecbond Basic Information, Manufacturing Base and Competitors
   Table 64. ChengDu Tecbond Major Business
   Table 65. ChengDu Tecbond Swine Vaccines Product and Services
   Table 66. ChengDu Tecbond Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 67. ChengDu Tecbond Recent Developments/Updates
   Table 68. DHN Basic Information, Manufacturing Base and Competitors
   Table 69. DHN Major Business
   Table 70. DHN Swine Vaccines Product and Services
   Table 71. DHN Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 72. DHN Recent Developments/Updates
   Table 73. CAVAC Basic Information, Manufacturing Base and Competitors
   Table 74. CAVAC Major Business
   Table 75. CAVAC Swine Vaccines Product and Services
   Table 76. CAVAC Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 77. CAVAC Recent Developments/Updates
   Table 78. Virbac Basic Information, Manufacturing Base and Competitors
   Table 79. Virbac Major Business
   Table 80. Virbac Swine Vaccines Product and Services
   Table 81. Virbac Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 82. Virbac Recent Developments/Updates
   Table 83. HVRI Basic Information, Manufacturing Base and Competitors
   Table 84. HVRI Major Business
   Table 85. HVRI Swine Vaccines Product and Services
   Table 86. HVRI Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 87. HVRI Recent Developments/Updates
   Table 88. Bioveta Basic Information, Manufacturing Base and Competitors
   Table 89. Bioveta Major Business
   Table 90. Bioveta Swine Vaccines Product and Services
   Table 91. Bioveta Swine Vaccines Sales Quantity (M Doses), Average Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 92. Bioveta Recent Developments/Updates
   Table 93. Global Swine Vaccines Sales Quantity by Manufacturer (2018-2023) & (M Doses)
   Table 94. Global Swine Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
   Table 95. Global Swine Vaccines Average Price by Manufacturer (2018-2023) & (USD/K Doses)
   Table 96. Market Position of Manufacturers in Swine Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
   Table 97. Head Office and Swine Vaccines Production Site of Key Manufacturer
   Table 98. Swine Vaccines Market: Company Product Type Footprint
   Table 99. Swine Vaccines Market: Company Product Application Footprint
   Table 100. Swine Vaccines New Market Entrants and Barriers to Market Entry
   Table 101. Swine Vaccines Mergers, Acquisition, Agreements, and Collaborations
   Table 102. Global Swine Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
   Table 103. Global Swine Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
   Table 104. Global Swine Vaccines Consumption Value by Region (2018-2023) & (USD Million)
   Table 105. Global Swine Vaccines Consumption Value by Region (2024-2029) & (USD Million)
   Table 106. Global Swine Vaccines Average Price by Region (2018-2023) & (USD/K Doses)
   Table 107. Global Swine Vaccines Average Price by Region (2024-2029) & (USD/K Doses)
   Table 108. Global Swine Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
   Table 109. Global Swine Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
   Table 110. Global Swine Vaccines Consumption Value by Type (2018-2023) & (USD Million)
   Table 111. Global Swine Vaccines Consumption Value by Type (2024-2029) & (USD Million)
   Table 112. Global Swine Vaccines Average Price by Type (2018-2023) & (USD/K Doses)
   Table 113. Global Swine Vaccines Average Price by Type (2024-2029) & (USD/K Doses)
   Table 114. Global Swine Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
   Table 115. Global Swine Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
   Table 116. Global Swine Vaccines Consumption Value by Application (2018-2023) & (USD Million)
   Table 117. Global Swine Vaccines Consumption Value by Application (2024-2029) & (USD Million)
   Table 118. Global Swine Vaccines Average Price by Application (2018-2023) & (USD/K Doses)
   Table 119. Global Swine Vaccines Average Price by Application (2024-2029) & (USD/K Doses)
   Table 120. North America Swine Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
   Table 121. North America Swine Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
   Table 122. North America Swine Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
   Table 123. North America Swine Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
   Table 124. North America Swine Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
   Table 125. North America Swine Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
   Table 126. North America Swine Vaccines Consumption Value by Country (2018-2023) & (USD Million)
   Table 127. North America Swine Vaccines Consumption Value by Country (2024-2029) & (USD Million)
   Table 128. Europe Swine Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
   Table 129. Europe Swine Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
   Table 130. Europe Swine Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
   Table 131. Europe Swine Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
   Table 132. Europe Swine Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
   Table 133. Europe Swine Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
   Table 134. Europe Swine Vaccines Consumption Value by Country (2018-2023) & (USD Million)
   Table 135. Europe Swine Vaccines Consumption Value by Country (2024-2029) & (USD Million)
   Table 136. Asia-Pacific Swine Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
   Table 137. Asia-Pacific Swine Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
   Table 138. Asia-Pacific Swine Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
   Table 139. Asia-Pacific Swine Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
   Table 140. Asia-Pacific Swine Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
   Table 141. Asia-Pacific Swine Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
   Table 142. Asia-Pacific Swine Vaccines Consumption Value by Region (2018-2023) & (USD Million)
   Table 143. Asia-Pacific Swine Vaccines Consumption Value by Region (2024-2029) & (USD Million)
   Table 144. South America Swine Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
   Table 145. South America Swine Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
   Table 146. South America Swine Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
   Table 147. South America Swine Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
   Table 148. South America Swine Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
   Table 149. South America Swine Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
   Table 150. South America Swine Vaccines Consumption Value by Country (2018-2023) & (USD Million)
   Table 151. South America Swine Vaccines Consumption Value by Country (2024-2029) & (USD Million)
   Table 152. Middle East & Africa Swine Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
   Table 153. Middle East & Africa Swine Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
   Table 154. Middle East & Africa Swine Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
   Table 155. Middle East & Africa Swine Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
   Table 156. Middle East & Africa Swine Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
   Table 157. Middle East & Africa Swine Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
   Table 158. Middle East & Africa Swine Vaccines Consumption Value by Region (2018-2023) & (USD Million)
   Table 159. Middle East & Africa Swine Vaccines Consumption Value by Region (2024-2029) & (USD Million)
   Table 160. Swine Vaccines Raw Material
   Table 161. Key Manufacturers of Swine Vaccines Raw Materials
   Table 162. Swine Vaccines Typical Distributors
   Table 163. Swine Vaccines Typical Customers

List of Figures

   Figure 1. Swine Vaccines Picture
   Figure 2. Global Swine Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Swine Vaccines Consumption Value Market Share by Type in 2022
   Figure 4. CSF Vaccines Examples
   Figure 5. FMD Vaccines Examples
   Figure 6. Porcine Circovirus Vaccines Examples
   Figure 7. PRRS Vaccines Examples
   Figure 8. Others Examples
   Figure 9. Global Swine Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Figure 10. Global Swine Vaccines Consumption Value Market Share by Application in 2022
   Figure 11. Government Tender Examples
   Figure 12. Market Sales Examples
   Figure 13. Global Swine Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 14. Global Swine Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 15. Global Swine Vaccines Sales Quantity (2018-2029) & (M Doses)
   Figure 16. Global Swine Vaccines Average Price (2018-2029) & (USD/K Doses)
   Figure 17. Global Swine Vaccines Sales Quantity Market Share by Manufacturer in 2022
   Figure 18. Global Swine Vaccines Consumption Value Market Share by Manufacturer in 2022
   Figure 19. Producer Shipments of Swine Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
   Figure 20. Top 3 Swine Vaccines Manufacturer (Consumption Value) Market Share in 2022
   Figure 21. Top 6 Swine Vaccines Manufacturer (Consumption Value) Market Share in 2022
   Figure 22. Global Swine Vaccines Sales Quantity Market Share by Region (2018-2029)
   Figure 23. Global Swine Vaccines Consumption Value Market Share by Region (2018-2029)
   Figure 24. North America Swine Vaccines Consumption Value (2018-2029) & (USD Million)
   Figure 25. Europe Swine Vaccines Consumption Value (2018-2029) & (USD Million)
   Figure 26. Asia-Pacific Swine Vaccines Consumption Value (2018-2029) & (USD Million)
   Figure 27. South America Swine Vaccines Consumption Value (2018-2029) & (USD Million)
   Figure 28. Middle East & Africa Swine Vaccines Consumption Value (2018-2029) & (USD Million)
   Figure 29. Global Swine Vaccines Sales Quantity Market Share by Type (2018-2029)
   Figure 30. Global Swine Vaccines Consumption Value Market Share by Type (2018-2029)
   Figure 31. Global Swine Vaccines Average Price by Type (2018-2029) & (USD/K Doses)
   Figure 32. Global Swine Vaccines Sales Quantity Market Share by Application (2018-2029)
   Figure 33. Global Swine Vaccines Consumption Value Market Share by Application (2018-2029)
   Figure 34. Global Swine Vaccines Average Price by Application (2018-2029) & (USD/K Doses)
   Figure 35. North America Swine Vaccines Sales Quantity Market Share by Type (2018-2029)
   Figure 36. North America Swine Vaccines Sales Quantity Market Share by Application (2018-2029)
   Figure 37. North America Swine Vaccines Sales Quantity Market Share by Country (2018-2029)
   Figure 38. North America Swine Vaccines Consumption Value Market Share by Country (2018-2029)
   Figure 39. United States Swine Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 40. Canada Swine Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 41. Mexico Swine Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 42. Europe Swine Vaccines Sales Quantity Market Share by Type (2018-2029)
   Figure 43. Europe Swine Vaccines Sales Quantity Market Share by Application (2018-2029)
   Figure 44. Europe Swine Vaccines Sales Quantity Market Share by Country (2018-2029)
   Figure 45. Europe Swine Vaccines Consumption Value Market Share by Country (2018-2029)
   Figure 46. Germany Swine Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 47. France Swine Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 48. United Kingdom Swine Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 49. Russia Swine Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 50. Italy Swine Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 51. Asia-Pacific Swine Vaccines Sales Quantity Market Share by Type (2018-2029)
   Figure 52. Asia-Pacific Swine Vaccines Sales Quantity Market Share by Application (2018-2029)
   Figure 53. Asia-Pacific Swine Vaccines Sales Quantity Market Share by Region (2018-2029)
   Figure 54. Asia-Pacific Swine Vaccines Consumption Value Market Share by Region (2018-2029)
   Figure 55. China Swine Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 56. Japan Swine Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 57. Korea Swine Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 58. India Swine Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 59. Southeast Asia Swine Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 60. Australia Swine Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 61. South America Swine Vaccines Sales Quantity Market Share by Type (2018-2029)
   Figure 62. South America Swine Vaccines Sales Quantity Market Share by Application (2018-2029)
   Figure 63. South America Swine Vaccines Sales Quantity Market Share by Country (2018-2029)
   Figure 64. South America Swine Vaccines Consumption Value Market Share by Country (2018-2029)
   Figure 65. Brazil Swine Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 66. Argentina Swine Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 67. Middle East & Africa Swine Vaccines Sales Quantity Market Share by Type (2018-2029)
   Figure 68. Middle East & Africa Swine Vaccines Sales Quantity Market Share by Application (2018-2029)
   Figure 69. Middle East & Africa Swine Vaccines Sales Quantity Market Share by Region (2018-2029)
   Figure 70. Middle East & Africa Swine Vaccines Consumption Value Market Share by Region (2018-2029)
   Figure 71. Turkey Swine Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 72. Egypt Swine Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 73. Saudi Arabia Swine Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 74. South Africa Swine Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 75. Swine Vaccines Market Drivers
   Figure 76. Swine Vaccines Market Restraints
   Figure 77. Swine Vaccines Market Trends
   Figure 78. Porters Five Forces Analysis
   Figure 79. Manufacturing Cost Structure Analysis of Swine Vaccines in 2022
   Figure 80. Manufacturing Process Analysis of Swine Vaccines
   Figure 81. Swine Vaccines Industrial Chain
   Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
   Figure 83. Direct Channel Pros & Cons
   Figure 84. Indirect Channel Pros & Cons
   Figure 85. Methodology
   Figure 86. Research Process and Data Source